Development of an individual score for melanoma risk

European Journal of Cancer Prevention

Volumn 20, Issue 3, 2011, Pages 217-224

  Quéreux, Gaelle ^a   Moyse, Dominique ^c   Lequeux, Yves ^a   Jumbou, Olivier ^a   Brocard, Anabelle ^a   Antonioli, Daniel ^b   Dréno, Brigitte ^a,b   Nguyen, Jean Michel ^b  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Statistician Department   (France)

Author keywords

melanoma; prevention; screening; skin cancer; targeted screening

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; ODDS RATIO; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; ROC CURVE; SELF-ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 79955076057     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834474ae     Document Type: Article

References (43)

1. Aitken JF, Elwood M, Baade PD, Youl P, English D (2010). Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer 126:450-458.
2. Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM (2001). Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol 44:979-986. (Pubitemid 32493449)
3. Burton RC, Howe C, Adamson L, Reid AL, Hersey P, Watson A, et al. (1998). General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen 5:156-161. (Pubitemid 28442999)
4. Buttner P, Garbe C, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 75:2499-2506.
5. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, et al. (2004). Selfdetected cutaneous melanomas in Italian patients. Clin Exp Dermatol 29:593-596. (Pubitemid 39573642)
6. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. (2009). Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 38:814-830.
7. Cho E, Rosner BA, Feskanich D, Colditz GA (2005). Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 23:2669-2675. (Pubitemid 46179456)
8. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I (2006). Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 17:21-27. (Pubitemid 43083666)
9. Cust AE, Schmid H, Maskiell JA, Jetann J, Ferguson M, Holland EA, et al. (2009). Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian melanoma family study. Am J Epidemiol 170:1541-1554.
10. De Vries E, Coebergh JW (2005). Melanoma incidence has risen in Europe. BMJ 331:698. (Pubitemid 41374854)
11. Downing A, Yu XQ, Newton-Bishop J, Forman D (2008). Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 123:861-866. (Pubitemid 352032413)
12. Eiser JR, Pendry L, Greaves CJ, Melia J, Harland C, Moss S (2000). Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening. J Med Screen 7:199-202. (Pubitemid 32099058)
13. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE (1999). Is physician detection associated with thinner melanomas? JAMA 281:640-643. (Pubitemid 29098065)
14. Fears TR, Guerry Dt, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, et al. (2006). Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 24:3590-3596. (Pubitemid 46630531)
15. Fortes C, Mastroeni S, Bakos L, Antonelli G, Alessandroni L, Pilla MA, et al. (2010). Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev 19:393-400.
16. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK (1999). Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 41:738-745. (Pubitemid 29514030)
17. Fry A, Verne J (2003). Preventing skin cancer. BMJ 326:114-115. (Pubitemid 36135561)
18. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. (2005a). Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28-44. (Pubitemid 40029657)
19. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. (2005b). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45-60. (Pubitemid 40029658)
20. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. (2005c). Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040-2059. (Pubitemid 41337946)
21. Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, et al. (2006). A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 107:806-814. (Pubitemid 44232673)
22. Harbauer A, Binder M, Pehamberger H, Wolff K, Kittler H (2003). Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res 13:537-542. (Pubitemid 37266957)
23. Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT (2001). Screening for skin cancer. Am J Prev Med 20:47-58. (Pubitemid 33732967)
24. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ (1995a). Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 141:923-933.
25. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ (1995b). Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 141:934-942.
26. Jackson A, Wilkinson C, Ranger M, Pill R, August P (1998). Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score. BMJ 316:34-38. (Pubitemid 28019867)
27. Jemal A, Devesa SS, Hartge P, Tucker MA (2001). Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93:678-683. (Pubitemid 32492808)
28. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009). Increasing burden of melanoma in the United States. J Invest Dermatol 129:1666-1674.
29. Loria D, Matos E (2001). Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol 40:108-114. (Pubitemid 32396557)
30. Losina E,Walensky RP, Geller A, Beddingfield FC III,Wolf LL, Gilchrest BA, et al. (2007). Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol 143:21-28. (Pubitemid 46143192)
31. MacKie RM, Freudenberger T, Aitchison TC (1989). Personal risk-factor chart for cutaneous melanoma. Lancet 2:487-490. (Pubitemid 19209152)
32. Masri GD, Clark WH Jr, Guerry Dt, Halpern A, Thompson CJ, Elder DE (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22:1042-1048. (Pubitemid 20186126)
33. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF (2003). Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 98:1223-1231. (Pubitemid 37099907)
34. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF (2006). Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 54:783-792. (Pubitemid 44382423)
35. Morrison A, O'Loughlin S, Powell FC (2001). Suspected skin malignancy: a comparison of diagnoses of family practitioners and dermatologists in 493 patients. Int J Dermatol 40:104-107. (Pubitemid 32396556)
36. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
37. Quereux G, Nguyen JM, Volteau C, Lequeux Y, Dreno B (2010). Creation and test of a questionnaire for self-assessment of melanoma risk factors. Eur J Cancer Prev 19:48-54.
38. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. (2000). Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 89:280-285. (Pubitemid 30430745)
39. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD (2001). Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774-781. (Pubitemid 32722180)
40. Williams HA, Fritschi L, Beauchamp C, Katris P (2006). Evaluating the usefulness of self-reported risk factors in a skin cancer screening program. Melanoma Res 16:341-345. (Pubitemid 44090178)
41. Wilson JM, Jungner YG (1968). Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65:281-393.
42. Wolfe JT (1999). The role of screening in the management of skin cancer. Curr Opin Oncol 11:123-128. (Pubitemid 29151471)
43. Wolff T, Tai E, Miller T (2009). Screening for skin cancer: an update of the evidence for the US preventive services task force. Ann Intern Med 150:194-198.